Adaptive platform trials: definition, design, conduct and reporting considerations - PubMed (original) (raw)
Review
. 2019 Oct;18(10):797-807.
doi: 10.1038/s41573-019-0034-3. Epub 2019 Aug 28.
Collaborators
- PMID: 31462747
- DOI: 10.1038/s41573-019-0034-3
Review
Adaptive platform trials: definition, design, conduct and reporting considerations
Adaptive Platform Trials Coalition. Nat Rev Drug Discov. 2019 Oct.
Erratum in
- Author Correction: Adaptive platform trials: definition, design, conduct and reporting considerations.
Adaptive Platform Trials Coalition. Adaptive Platform Trials Coalition. Nat Rev Drug Discov. 2019 Oct;18(10):808. doi: 10.1038/s41573-019-0045-0. Nat Rev Drug Discov. 2019. PMID: 31506612
Abstract
Researchers, clinicians, policymakers and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing, parallel-group randomized controlled trials (RCTs). Examples include scenarios in which there is a desire to compare multiple interventions, to generate separate effect estimates across subgroups of patients with distinct but related conditions or clinical features, or to minimize downtime between trials. In response, researchers have proposed new RCT designs such as adaptive platform trials (APTs), which are able to study multiple interventions in a disease or condition in a perpetual manner, with interventions entering and leaving the platform on the basis of a predefined decision algorithm. APTs offer innovations that could reshape clinical trials, and several APTs are now funded in various disease areas. With the aim of facilitating the use of APTs, here we review common features and issues that arise with such trials, and offer recommendations to promote best practices in their design, conduct, oversight and reporting.
Similar articles
- Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Higashida RT, et al. Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717 - This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
Schiavone F, Bathia R, Letchemanan K, Masters L, Amos C, Bara A, Brown L, Gilson C, Pugh C, Atako N, Hudson F, Parmar M, Langley R, Kaplan RS, Parker C, Attard G, Clarke NW, Gillessen S, James ND, Maughan T, Sydes MR; past and present members of the STAMPEDE and FOCUS4 Trial Management Group. Schiavone F, et al. Trials. 2019 May 29;20(1):264. doi: 10.1186/s13063-019-3216-8. Trials. 2019. PMID: 31138317 Free PMC article. - A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AM. MacLehose RR, et al. Health Technol Assess. 2000;4(34):1-154. Health Technol Assess. 2000. PMID: 11134917 Review. - Practical clinical trials for translating research to practice: design and measurement recommendations.
Glasgow RE, Magid DJ, Beck A, Ritzwoller D, Estabrooks PA. Glasgow RE, et al. Med Care. 2005 Jun;43(6):551-7. doi: 10.1097/01.mlr.0000163645.41407.09. Med Care. 2005. PMID: 15908849 - OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for primary prevention of osteoarthritis by joint injury prevention in sport and recreation.
Emery CA, Roos EM, Verhagen E, Finch CF, Bennell KL, Story B, Spindler K, Kemp J, Lohmander LS. Emery CA, et al. Osteoarthritis Cartilage. 2015 May;23(5):815-25. doi: 10.1016/j.joca.2015.03.009. Osteoarthritis Cartilage. 2015. PMID: 25952352 Review.
Cited by
- Adaptive designs in clinical trials: a systematic review-part I.
Ben-Eltriki M, Rafiq A, Paul A, Prabhu D, Afolabi MOS, Baslhaw R, Neilson CJ, Driedger M, Mahmud SM, Lacaze-Masmonteil T, Marlin S, Offringa M, Butcher N, Heath A, Kelly LE. Ben-Eltriki M, et al. BMC Med Res Methodol. 2024 Oct 4;24(1):229. doi: 10.1186/s12874-024-02272-9. BMC Med Res Methodol. 2024. PMID: 39367313 Free PMC article. - Reporting and communication of sample size calculations in adaptive clinical trials: a review of trial protocols and grant applications.
Zhang Q, Dimairo M, Julious SA, Lewis J, Yu Z. Zhang Q, et al. BMC Med Res Methodol. 2024 Sep 27;24(1):216. doi: 10.1186/s12874-024-02339-7. BMC Med Res Methodol. 2024. PMID: 39333920 Free PMC article. Review. - Adaptive Trials in Stroke: Current Use and Future Directions.
Hayward KS, Dalton EJ, Campbell BCV, Khatri P, Dukelow SP, Johns H, Walter S, Yogendrakumar V, Pandian JD, Sacco S, Bernhardt J, Parsons MW, Saver JL, Churilov L. Hayward KS, et al. Neurology. 2024 Oct 22;103(8):e209876. doi: 10.1212/WNL.0000000000209876. Epub 2024 Sep 26. Neurology. 2024. PMID: 39325999 Review. - Adaptive platform trials in critical care.
Vignarajah M, Rochwerg B. Vignarajah M, et al. J Intensive Med. 2024 May 29;4(4):478-479. doi: 10.1016/j.jointm.2024.04.002. eCollection 2024 Oct. J Intensive Med. 2024. PMID: 39310060 Free PMC article. No abstract available. - Home-monitoring for neovascular age-related macular degeneration in older adults within the UK: the MONARCH diagnostic accuracy study.
Hogg RE, Wickens R, O'Connor S, Gidman E, Ward E, Treanor C, Peto T, Burton B, Knox P, Lotery AJ, Sivaprasad S, Donnelly M, Rogers CA, Reeves BC. Hogg RE, et al. Health Technol Assess. 2024 Jul;28(32):1-136. doi: 10.3310/CYRA9912. Health Technol Assess. 2024. PMID: 39023220 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical